Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12

被引:175
作者
Yao, L
Sgadari, C
Furuke, K
Bloom, ET
Teruya-Feldstein, J
Tosato, G
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Hematol Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Hematopathol Sect, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V93.5.1612.405a13_1612_1621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induced angiogenesis in athymic mice. By immunohistochemistry, those sites where bFGF-induced neovascularization was inhibited by IL-12 displayed accumulation of NK cells and the presence of IP-10-positive cells. Based on expression of the cytolytic mediators perforin and granzyme B, the NK cells were locally activated. Experimental Burkitt lymphomas treated locally with IL-12 displayed tumor tissue necrosis, vascular damage, and NK-cell infiltration surrounding small vessels. After activation in vitro with IL-12 NK cells from nude mice became strongly cytotoxic for primary cultures of syngeneic aortic endothelial cells. Cytotoxicity was neutralized by antibodies to IFN-gamma. These results document that NK cells are required mediators of angiogenesis inhibition by IL-12 and provide evidence that NK-cell cytotoxicity of endothelial cells is a potential mechanism by which IL-12 can suppress neovascularization.
引用
收藏
页码:1612 / 1621
页数:10
相关论文
共 53 条
  • [11] PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    DANDREA, A
    RENGARAJU, M
    VALIANTE, NM
    CHEHIMI, J
    KUBIN, M
    ASTE, M
    CHAN, SH
    KOBAYASHI, M
    YOUNG, D
    NICKBARG, E
    CHIZZONITE, R
    WOLF, SF
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1387 - 1398
  • [12] Mig and IP-10: CXC chemokines that target lymphocytes
    Farber, JM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (03) : 246 - 257
  • [13] THE REGULATION OF BLOOD-VESSEL GROWTH BY VASCULAR ENDOTHELIAL GROWTH-FACTOR
    FERRARA, N
    HEINSOHN, H
    WALDER, CE
    BUNTING, S
    THOMAS, GR
    [J]. CARDIAC GROWTH AND REGENERATION, 1995, 752 : 246 - 256
  • [14] Blood vessel formation: What is its molecular basis?
    Folkman, J
    DAmore, PA
    [J]. CELL, 1996, 87 (07) : 1153 - 1155
  • [15] ADMINISTRATION OF RECOMBINANT IL-12 TO NORMAL MICE ENHANCES CYTOLYTIC LYMPHOCYTE ACTIVITY AND INDUCES PRODUCTION OF IFN-GAMMA IN-VIVO
    GATELY, MK
    WARRIER, RR
    HONASOGE, S
    CARVAJAL, DM
    FAHERTY, DA
    CONNAUGHTON, SE
    ANDERSON, TD
    SARMIENTO, U
    HUBBARD, BR
    MURPHY, M
    [J]. INTERNATIONAL IMMUNOLOGY, 1994, 6 (01) : 157 - 167
  • [16] RECOMBINANT INTERLEUKIN-12 CURES MICE INFECTED WITH LEISHMANIA-MAJOR
    HEINZEL, FP
    SCHOENHAUT, DS
    RERKO, RM
    ROSSER, LE
    GATELY, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) : 1505 - 1509
  • [17] DEVELOPMENT OF TH1 CD4+ T-CELLS THROUGH IL-12 PRODUCED BY LISTERIA-INDUCED MACROPHAGES
    HSIEH, CS
    MACATONIA, SE
    TRIPP, CS
    WOLF, SF
    OGARRA, A
    MURPHY, KM
    [J]. SCIENCE, 1993, 260 (5107) : 547 - 549
  • [18] Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature
    Huang, XM
    Molema, G
    King, S
    Watkins, L
    Edgington, TS
    Thorpe, PE
    [J]. SCIENCE, 1997, 275 (5299) : 547 - 550
  • [19] Contribution of the CXC chemokines IF-10 and Mig to the antitumor effects of IL-12
    Kanegane, C
    Sgadari, C
    Kanegane, H
    Teruya-Feldstein, J
    Yao, L
    Gupta, G
    Farber, JM
    Liao, F
    Liu, L
    Tosato, G
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) : 384 - 392
  • [20] A GLYCOLIPID ON THE SURFACE OF MOUSE NATURAL-KILLER CELLS
    KASAI, M
    IWAMORI, M
    NAGAI, Y
    OKUMURA, K
    TADA, T
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1980, 10 (03) : 175 - 180